These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17500227)

  • 1. [Treatment for progressive pulmonary tuberculosis with a complex of stress-limiting drugs].
    Filippova TP; Vasil'eva LS
    Probl Tuberk Bolezn Legk; 2007; (3):38-42. PubMed ID: 17500227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Exacerbation of pulmonary tuberculosis during chemotherapy].
    Karachunskii MA
    Probl Tuberk; 1996; (5):23-5. PubMed ID: 8984483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of prednisolone on the cardiovascular system in complex treatment of newly detected pulmonary tuberculosis].
    Piatnochka IT
    Vrach Delo; 1975 Oct; (10):47-9. PubMed ID: 1231222
    [No Abstract]   [Full Text] [Related]  

  • 4. [Peribronchial lymphotropic therapy in the combined treatment of patients with progressive pulmonary tuberculosis].
    Pletnev GV; Krasnov DV
    Probl Tuberk Bolezn Legk; 2003; (12):3-5. PubMed ID: 15004961
    [No Abstract]   [Full Text] [Related]  

  • 5. [New-onset pulmonary tuberculosis patients with schizophrenia: course and efficiency of treatment].
    Mishin VIu; Shevchuk EIu; Tsygankov BD; Losev LV
    Probl Tuberk Bolezn Legk; 2008; (6):6-10. PubMed ID: 18710046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pathogenetic therapy for caseous pneumonia].
    Chelnokova OG; Kibrik BS
    Probl Tuberk Bolezn Legk; 2004; (7):25-8. PubMed ID: 15379037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in the patients' mental status in the tolerability of antituberculous drugs].
    Mordyk AV; Briukhanova NS; Kazakov AV
    Probl Tuberk Bolezn Legk; 2009; (3):38-42. PubMed ID: 19455986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
    Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Use of alpha-tocopherol acetate in the treatment of hemodynamic disorders in patients with pulmonary tuberculosis].
    Ditiatkov AE; Tikhonov VA; Radzevich AE; Zholnin PA
    Probl Tuberk Bolezn Legk; 2005; (6):46-8. PubMed ID: 16078723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment and outcomes of tuberculosis with multidrug resistance of MBT in children and adolescents].
    Panova LV; Ovsiankina ES
    Probl Tuberk Bolezn Legk; 2007; (5):20-2. PubMed ID: 17600925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antioxidants in the combined therapy of patients with chronic destructive pulmonary tuberculosis].
    Ivanova LA; Pavlova MV; Archakova LI
    Ter Arkh; 1994; 66(11):54-6. PubMed ID: 7900021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Change in adrenal cortex function during complex treatment of patients with tuberculosis].
    Golenitskiĭ AI
    Vrach Delo; 1967; 9():85-7. PubMed ID: 5621789
    [No Abstract]   [Full Text] [Related]  

  • 13. A paradoxical reaction during antituberculosis therapy for congenital tuberculosis.
    Park JA; Park SS; Park SE
    Int J Infect Dis; 2009 Sep; 13(5):e279-81. PubMed ID: 19124260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Examination of administrative dosage of cyclosporine during anti-tuberculosis chemotherapy including rifampicin].
    Matsui Y; Akagawa S; Kawashima M; Suzuki J; Masuda K; Tamura A; Nagai H; Nagayama N; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2007 Jul; 82(7):563-7. PubMed ID: 17695786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glutoxim in the surgical treatment of patients with pulmonary tuberculosis].
    Sinitsyn MV; Bogadel'nikova IV
    Probl Tuberk Bolezn Legk; 2007; (5):17-20. PubMed ID: 17598458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative effectiveness of etiopathogenetic therapy in adolescents with destructive pulmonary tuberculosis].
    Pavlova MV; Ivanova lA; Titarenko OT; Perova TL
    Probl Tuberk; 1994; (2):45-6. PubMed ID: 8036221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with small-volume plasmapheresis used in the correction of hemostatic disorders in patients with progressive destructive pulmonary tuberculosis].
    Karpina NL; Kaminskaia GO; Serebrianaia BA; Erokhin VV
    Probl Tuberk Bolezn Legk; 2007; (11):33-7. PubMed ID: 18080532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of nonspecific responsiveness from adaptive reactions in patients with destructive pulmonary tuberculosis].
    Ubaĭdullaev AM; Tashpulatova FK
    Probl Tuberk Bolezn Legk; 2008; (6):18-21. PubMed ID: 18710050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Biochemical basis of use of pathogenetic therapy in pulmonary tuberculosis].
    Gur'eva IG; Andrzheiuk NI; Smirnova NA
    Probl Tuberk; 1978 Nov; (11):27-30. PubMed ID: 31620
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.